1. Yabuuchi E, Oyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol. 1971; 15:477–481.
2. Coenye T, Vancanneyt M, Falsen E, Swings J, Vandamme P. Achromobacter insolitus sp. nov. and Achromobacter spanius sp. nov., from human clinical samples. Int J Syst Evol Microbiol. 2003; 53:1819–1824.
Article
3. Reverdy ME, Freney J, Fleurette J, et al. Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol. 1984; 19:140–143.
Article
4. Taylor P, Fischbein L. Prosthetic knee infection due to Achromobacter xylosoxidans. J Rheumatol. 1992; 19:992–993.
5. Ramos JM, Domine M, Ponte MC, Soriano F. Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans Description of 3 cases and review of the literature. Enferm Infecc Microbiol Clin. 1996; 14:436–440.
6. Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis. 2008; 47:1403–1409.
Article
7. Gales AC, Jones RN, Andrade SS, Sader HS. Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Mem Inst Oswaldo Cruz. 2005; 100:571–577.
Article
8. Frommelt L. Principles of systemic antimicrobial therapy in foreign material associated infection in bone tissue, with special focus on periprosthetic infection. Injury. 2006; 37:Suppl 2. S87–S94.
Article